United StatesOxoid Agglutinating Sera, Salmonella 9-0 (R30957301; UDI‑DI 05056080500270) in lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, and 6233859 is affected; 117 units were distributed in the US and 950 outside the US, with US distribution to AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, and WA and worldwide otherwise. The lots were recalled because they are not performing to IFU criteria, showing cross‑reactions with 2‑0 within 60 seconds that may lead to misidentifying a Salmonella 9‑O serotype as a 2‑O serotype.
What's being recalled
Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
Recalling firm: Remel Europe Ltd., Dartford, N/A, United Kingdom.
How to identify it
UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
The hazard
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)